For the year ending 2025-12-31, IRWD made $296,151K in revenue. $24,017K in net income. Net profit margin of 8.11%.
| Income Statement | 2025-12-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Total revenues | 296,151 | 351,410 | ||
| Research and development | 95,136 | 111,421 | ||
| Selling, general and administrative | 82,256 | 144,272 | ||
| Restructuring, net | 20,257 | 2,593 | ||
| Total costs and expenses | 197,649 | 258,286 | ||
| Income from operations | 98,502 | 93,124 | ||
| Interest expense and other financing costs | 32,746 | 33,034 | ||
| Interest and investment income | 4,076 | 4,468 | ||
| Other | 193 | 640 | ||
| Other income (expense), net | -28,477 | -27,926 | ||
| Income before income taxes | 70,025 | 65,198 | ||
| Income tax expense | 46,008 | 64,318 | ||
| Net income (loss) | - | 880 | ||
| Net income | 24,017 | 880 | ||
| Basic EPS | 0.15 | 0.01 | ||
| Diluted EPS | 0.15 | 0.01 | ||
| Basic Average Shares | 161,842,000 | 159,083,000 | ||
| Diluted Average Shares | 162,983,000 | 160,084,000 | ||
IRONWOOD PHARMACEUTICALS INC (IRWD)
IRONWOOD PHARMACEUTICALS INC (IRWD)